Our Research
Clovis Oncology is Testing Rubraca ® For Multiple Oncology Indications, Analysts Review and Target
Clovis Oncology, Inc. (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents...
Pacific Biosciences Agrees to be Acquired in an All Cash Transaction, Analysts Review
Pacific Biosciences of California, Inc. (NASDAQ: PACB) offers sequencing systems to help scientists resolve genetically complex problems. The Compan...
Exelixis Revenues for Cabozantinib Continue to Grow, Clinical Development and Regulatory Progress
Exelixis, Inc. (NASDAQ: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, developme...